Page - 88 - in Cancer Nanotheranostics - What Have We Learnd So Far?

Conniotet al. Nanocarriers for immunecell targetingand tracking Ewert, K., Evans, H. M., Ahmad, A., Slack, N. L., Lin, A. J., Martin- Herranz, A., et al. (2005). Lipoplex structures and their distinct cel- lular pathways. Adv. Genet. 53, 119–155. doi: 10.1016/S0065-2660(05) 53005-0 Fang, J., Nakamura, H., andMaeda, H. (2011). The EPR effect: unique features of tumorblood vessels for drugdelivery, factors involved, and limitations and augmentation of the effect.Adv. DrugDeliv. Rev. 63, 136–151. doi: 10.1016/j. addr.2010.04.009 Fernald,K.,andKurokawa,M.(2013).Evadingapoptosisincancer.TrendsCellBiol. 23,620–633.doi:10.1016/j.tcb.2013.07.006 Florindo,H.F.,Pandit,S.,Goncalves,L.M.,Alpar,H.O.,andAlmeida,A.J.(2008). Streptococcus equi antigens adsorbed onto surface modified poly-epsilon- caprolactone microspheres induce humoral and cellular specific immune responses.Vaccine26,4168–4177.doi:10.1016/j.vaccine.2008.05.074 Florindo,H. F., Pandit, S.,Goncalves, L.M.,Videira,M.,Alpar,O., andAlmeida, A. J. (2009a). Antibody and cytokine-associated immune responses to S. equi antigens entrapped in PLA nanospheres. Biomaterials 30, 5161–5169. doi: 10.1016/j.biomaterials.2009.05.045 Florindo,H.F.,Pandit,S.,Lacerda,L.,Goncalves,L.M.,Alpar,H.O.,andAlmeida, A. J. (2009b). The enhancement of the immune response against S. equi anti- gens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles.Biomaterials30,879–891.doi:10.1016/j.biomaterials.2008.10.035 Foged,C.,Brodin,B.,Frokjaer,S.,andSundblad,A.(2005).Particlesizeandsurface chargeaffectparticleuptakebyhumandendritic cells inan in vitromodel. Int. J.Pharm.298,315–322.doi:10.1016/j.ijpharm.2005.03.035 Fong, L., and Engleman, E.G. (2000).Dendritic cells in cancer immunotherapy. Annu.Rev. Immunol.18,245–273.doi:10.1146/annurev.immunol.18.1.245 Fortis, C., Foppoli, M., Gianotti, L., Galli, L., Citterio, G., Consogno, G., et al. (1996). Increased interleukin-10 serum levels in patients with solid tumours. CancerLett.104,1–5. Frank, J. A., Miller, B. R., Arbab, A. S., Zywicke, H. A., Jordan, E. K., Lewis, B. K., et al. (2003).Clinically applicable labelingofmammalianand stemcells by combining superparamagnetic iron oxides and transfection agents.Radiology 228,480–487.doi:10.1148/radiol.2281020638 Frank,M.M. (1993). The reticuloendothelial system andbloodstream clearance. J.Lab.Clin.Med.122,487–488. Freichels,H.,Pourcelle,V.,Auzely-Velty,R.,Marchand-Brynaert, J., andJerome,C. (2012). Synthesis of poly(lactide-co-glycolide-co-epsilon-caprolactone)-graft- mannosylated poly(ethylene oxide) copolymers by combination of “clip” and “click”chemistries.Biomacromolecules13,760–768.doi:10.1021/bm201690w Fuertes,M. B., Kacha, A. K., Kline, J.,Woo, S. R., Kranz,D.M.,Murphy, K.M., et al. (2011).Host type I IFN signals are required for antitumorCD8+Tcell responses throughCD8{alpha}+dendritic cells. J. Exp.Med. 208, 2005–2016. doi:10.1084/jem.20101159 Gajewski, T. F. (2012). Cancer immunotherapy. Mol. Oncol. 6, 242–250. doi: 10.1016/j.molonc.2012.01.002 Gajewski, T. F., Schreiber,H., and Fu, Y. X. (2013). Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 14, 1014–1022. doi: 10.1038/ni.2703 Gajos-Michniewicz,A.,Duechler,M.,andCzyz,M.(2014).MiRNAinmelanoma- derivedexosomes.CancerLett.347,29–37.doi:10.1016/j.canlet.2014.02.004 Ganta,S.,Devalapally,H.,Shahiwala,A.,andAmiji,M.(2008).Areviewofstimuli- responsive nanocarriers for drug and gene delivery. J. Control. Release 126, 187–204.doi:10.1016/j.jconrel.2007.12.017 Gao, H., Xiong, Y., Zhang, S., Yang, Z., Cao, S., and Jiang, X. (2014). RGD and interleukin-13peptide functionalizednanoparticles for enhancedglioblastoma cellsandneovasculaturedualtargetingdeliveryandelevatedtumorpenetration. Mol.Pharm. 11,1042–1052.doi:10.1021/mp400751g Gao,X.,Cui,Y., Levenson,R.M.,Chung,L.W., andNie, S. (2004). Invivo cancer targeting and imagingwith semiconductor quantumdots.Nat. Biotechnol.22, 969–976.doi:10.1038/nbt994 Garrido,F., andAlgarra, I. (2001).MHCantigensandtumorescapefromimmune surveillance. Adv. Cancer Res. 83, 117–158. doi: 10.1016/S0065-230X(01) 83005-0 Gelperina,S.,Kisich,K.,Iseman,M.D.,andHeifets,L.(2005).Thepotentialadvan- tages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am.J.Respir.Crit.CareMed.172,1487–1490.doi:10.1164/rccm.200504-613PP Gianella, A., Jarzyna, P. A., Mani, V., Ramachandran, S., Calcagno, C., Tang, J., et al. (2011). Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. ACS Nano 5, 4422–4433. doi: 10.1021/nn103336a Gilad, A. A., Walczak, P., McMahon,M. T., Na, H. B., Lee, J. H., An, K., et al. (2008).MR tracking of transplanted cellswith “positive contrast” usingman- ganese oxide nanoparticles.Magn. Reson. Med. 60, 1–7. doi: 10.1002/mrm. 21622 Gilewski,T.A.,Ragupathi,G.,Dickler,M.,Powell, S.,Bhuta,S.,Panageas,K., et al. (2007). Immunization of high-risk breast cancer patients with clustered sTn- KLH conjugate plus the immunologic adjuvant QS-21.Clin. Cancer Res. 13, 2977–2985.doi:10.1158/1078-0432.CCR-06-2189 Girardi,M.,Oppenheim,D.E.,Steele,C.R.,Lewis, J.M.,Glusac,E.,Filler,R.,etal. (2001).RegulationofcutaneousmalignancybygammadeltaTcells.Science294, 605–609.doi:10.1126/science.1063916 Gogolak, P., Rethi, B., Hajas, G., and Rajnavolgyi, E. (2003). Targeting dendritic cells forprimingcellular immuneresponses. J.Mol.Recognit.16,299–317.doi: 10.1002/jmr.650 Gooden, M. J., De Bock, G. H., Leffers, N., Daemen, T., and Nijman, H. W. (2011). The prognostic influence of tumour-infiltrating lymphocytes in can- cer: a systematic review with meta-analysis. Br. J. Cancer 105, 93–103. doi: 10.1038/bjc.2011.189 Gorner, T., Gref, R.,Michenot, D., Sommer, F., Tran,M.N., andDellacherie, E. (1999). Lidocaine-loaded biodegradable nanospheres. I. OptimizationOf the drug incorporation into thepolymermatrix. J.Control.Release57,259–268. Grange,C.,Geninatti-Crich,S.,Esposito,G.,Alberti,D.,Tei,L.,Bussolati,B., et al. (2010).Combineddeliveryandmagneticresonanceimagingofneuralcelladhe- sion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi’s sarcoma. Cancer Res. 70, 2180–2190. doi: 10.1158/0008- 5472.CAN-09-2821 Gratton,S.E.,Ropp,P.A.,Pohlhaus,P.D.,Luft, J.C.,Madden,V. J.,Napier,M.E., et al. (2008).The effect of particle designoncellular internalizationpathways. Proc.Natl.Acad.Sci.U.S.A.105,11613–11618.doi:10.1073/pnas.0801763105 Greenberg,N.M.,Demayo,F., Finegold,M. J.,Medina,D.,Tilley,W.D.,Aspinall, J.O., et al. (1995). Prostate cancer in a transgenicmouse.Proc.Natl.Acad. Sci. U.S.A.92,3439–3443. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery,C., andAmigorena, S. (2002). Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol.20,621–667.doi:10.1146/annurev.immunol.20.100301.064828 Hamdy, S.,Haddadi, A.,Hung, R.W., andLavasanifar, A. (2011). Targeting den- driticcellswithnano-particulatePLGAcancervaccine formulations.Adv.Drug Deliv.Rev.63,943–955.doi:10.1016/j.addr.2011.05.021 Hanahan,D.,andWeinberg,R.A.(2000).Thehallmarksofcancer.Cell100,57–70. doi:10.1016/S0092-8674(00)81683-9 Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., Van De Kaa, C. H., et al. (2003). Noninvasive detection of clinically occult lymph-nodemetastases inprostatecancer.N.Engl. J.Med.348,2491–2499.doi: 10.1056/NEJMoa022749 Hashim, Z., Green, M., Chung, P. H., Suhling, K., Protti, A., Phinikaridou, A., et al. (2014). Gd-containing conjugated polymer nanoparticles: bimodal nanoparticles forfluorescence andMRI imaging.Nanoscale6, 8376–8386.doi: 10.1039/c4nr01491j Hawrylak, N., Ghosh, P., Broadus, J., Schlueter, C., Greenough, W. T., and Lauterbur, P. C. (1993). Nuclear magnetic resonance (NMR) imaging of iron oxide-labeled neural transplants. Exp. Neurol. 121, 181–192. doi: 10.1006/exnr.1993.1085 He,X.,Chen,J.,Wang,K.,Qin,D.,andTan,W.(2007).Preparationof luminescent Cy5 doped core-shell SFNPs and its application as a near-infrared fluorescent marker.Talanta72,1519–1526.doi:10.1016/j.talanta.2007.01.069 He, X., Duan, J., Wang, K., Tan,W., Lin, X., and He, C. (2004). A novel fluo- rescent label based on organic dye-doped silica nanoparticles for HepG liver cancer cell recognition. J. Nanosci. Nanotechnol. 4, 585–589. doi: 10.1166/jnn. 2004.011 He, X.,Wang, K., Tan,W., Li, J., Yang, X., Huang, S., et al. (2002). Photostable luminescent nanoparticles as biological label for cell recognition of sys- tem lupus erythematosus patients. J. Nanosci. Nanotechnol. 2, 317–320. doi: 10.1166/jnn.2002.105 Helfer, B. M., Balducci, A., Nelson, A. D., Janjic, J. M., Gil, R. R., Kalinski, P., et al. (2010).Functional assessmentofhumandendritic cells labeled for invivo (19)Fmagnetic resonance imaging cell tracking.Cytotherapy12, 238–250. doi: 10.3109/14653240903446902 www.frontiersin.org November2014 |Volume2 |Article105 | 88